Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

February Announcements On UK’s Medtech Regulatory System Change Awaited

UKCA regulatory update from industry: January 2023

Executive Summary

Much preparation work is underway among industry and the authorities as the UK seeks to nail down what kind of medtech regulatory system it wants for the future. Hosting an update session were the ABHI’s Phil Brown and Steve Lee.

You may also be interested in...



UK Proposal On Foreign Device Approval Recognition Due February

The Life Sciences Council has agreed to issue proposals on how the UK should recognize approvals granted by other trusted medical device regulatory jurisdictions. The need for speed in all matters relating to the UK’s sovereign medtech regulatory system has been stressed by the UK devices industry.

UK Medtech Strategy Promises To Use Innovation Effectively And Build Resilience

The UK MedTech Directorate has issued its much-awaited medical technology strategy for improving supply resilience and encouraging innovative and dynamic markets and sector diversity.

EU Regulatory Round-Up, January 2023: Cautious Optimism As New MDR Proposal Unveiled

All eyes were on the European Commission in January as it edged closer to adopting new legislation that will see the Medical Device Regulation transition deadlines extended.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel